For the year ending 2025-12-31, MCRB has $138,193K in assets. $93,975K in debts. $45,766K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 45,766 | |||
| Accounts receivable due from spn - related party | 360 | |||
| Accounts receivable | 157 | |||
| Prepaid expenses and other current assets | 3,093 | |||
| Total current assets | 49,376 | |||
| Property and equipment, gross | 64,248 | |||
| Less accumulated depreciation and amortization | 56,613 | |||
| Property and equipment, net | 7,635 | |||
| Operating lease assets | 72,483 | |||
| Restricted cash | 8,668 | |||
| Other non-current assets | 31 | |||
| Total assets | 138,193 | |||
| Accounts payable | 1,682 | |||
| Accrued expenses and other current liabilities | 3,972 | |||
| Accrued liabilities due to spn - related party | 3,278 | |||
| Operating lease liabilities | 10,390 | |||
| Total current liabilities | 19,322 | |||
| Operating lease liabilities, net of current portion | 72,576 | |||
| Other long-term liabilities | 2,077 | |||
| Total liabilities | 93,975 | |||
| Common stock, 0.001 par value 360,000,000 shares authorized at december 31, 2025 and 2024, respectively 9,556,446 and 8,650,227 shares issued and outstanding at december 31, 2025 and 2024, respectively | 10 | |||
| Additional paid-in capital | 1,016,611 | |||
| Accumulated deficit | -972,403 | |||
| Total stockholders' equity | 44,218 | |||
| Total liabilities and stockholders' equity | 138,193 | |||
Seres Therapeutics, Inc. (MCRB)
Seres Therapeutics, Inc. (MCRB)